Alloxazine

CAS No. 490-59-5

Alloxazine( —— )

Catalog No. M27527 CAS No. 490-59-5

Alloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 Get Quote
10MG 51 Get Quote
25MG 85 Get Quote
50MG 124 Get Quote
100MG 178 Get Quote
200MG 267 Get Quote
500MG 461 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Alloxazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Alloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.
  • Description
    Alloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.
  • In Vitro
    Alloxazine (0-30 μM, 20 min) inhibits cyclic AMP production in PGT-β cells. Cell Viability Assay Cell Line:PGT-β cells Concentration:0-30 μM Incubation Time:20 min Result:Inhibited the cyclic AMP generation concentration-dependently with an IC50 of 2.9 μM.
  • In Vivo
    Alloxazine (1 μmol/L; cortical surface suffusion for 0-20 min) suppresses NECA-induced vasodilation. Animal Model:Male Sprague-Dawley rats Dosage:1 μmol/L Administration:Cortical surface suffusion; 1 μmol/L once Result:Significantly suppressed vasodilation with increased EC25 value of 0.60 μmol/L.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Adenosine Receptor
  • Recptor
    glucokinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    490-59-5
  • Formula Weight
    214.184
  • Molecular Formula
    C10H6N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (23.34 mM)
  • SMILES
    O=c1[nH]c2nc3ccccc3nc2c(=O)[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dzyurkevich MS, et al. Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus. Sci Rep. 2017 Nov 22;7(1):16072.
molnova catalog
related products
  • Preladenant

    A potent and highly selective A2A receptor competitive antagonist with Ki of 1.1 nM.

  • Xanthine amine conge...

    Xanthine amine congener trihydrochloride is a potent adenosine antagonist that reverses the reduction in urine flow, sodium excretion and heart rate produced by the adenosine agonist, N6-cyclohexyladenosine.

  • DPCPX

    DPCPX is an A1 adenosine receptor antagonist